Skip to main content

Current Analysis: Elekta AB [EKTAF]

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy. Over the past year, Elekta's share price dropped 17.3% from $8.34 to $6.28 as of Monday’s market close.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.